Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05073991
Other study ID # 798/2564(IRB3)
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 23, 2021
Est. completion date December 31, 2023

Study information

Verified date October 2021
Source Mahidol University
Contact Sirilak Suksompong, MD
Phone 66891534806
Email sirilak.suk@mahidol.ac.th
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Lung surgery, open aortic surgery, TEVAR, and EVAR are major operations that carry a higher incidence of perioperative mortality and complications compare to other surgery. The study of the incidence of mortality and complications will help the hospital to benchmark with the others. Also the study of the risk factors of mortality and major complications will help to improve the patients' outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 2224
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients underwent - thoracic surgery - open thoracic aortic surgery - TEVAR - EVAR Exclusion Criteria: - Emergency lung surgery - Conversion from TEVAR to open thoracic surgery - Conversion from EVAR to open aortic surgery

Study Design


Intervention

Procedure:
Lung surgery
Patients underwent lung surgery including wedge resection, lobectomy, segmentectomy, and pneumonectomy.
Open aortic surgery
Patients underwent open thoracic surgery or thoracoabdominal aortic surgery.
TEVAR
Patients underwent TEVAR.
EVAR
Patients underwent EVAR.

Locations

Country Name City State
Thailand Anesthesiology Department Siriraj Hospital Bangkoknoi Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Other Incidence of postoperative delirium The patients with postoperative delirium required treatment will be described. 30 days
Other Incidence of low muscle mass Psoas muscle index will be used for the diagnosis of low muscle mass. Psoas muscle index = both psoas muscle area at L3 (from CT scan) divided by body surface area.
Cut-off values of sarcopenia
Male 68.5 cm2/m2
Female 52.5 cm2/m2
7 days
Other Risk factors of postoperative stroke. To identify risk factors eg. smoking, type of surgery, age, etc. 30 days
Primary Incidence of mortality and major complications after lung surgery The mortality and major complications (CVS, CNS, RS and others) will be recorded. 30 days
Primary Incidence of mortality and major complications after open aortic surgery The mortality and major complications (CVS, CNS, RS and others) will be recorded. 30 days
Primary Incidence of mortality and major complications after TEVAR The mortality and major complications (CVS, CNS, RS and others) will be recorded. 30 days
Primary Incidence of mortality and major complications after EVAR The mortality and major complications (CVS, CNS, RS and others) will be recorded. 30 days
Secondary Risk factors of mortality and major complications after lung surgery To identify risk factors eg. smoking, type of surgery, age, etc. 30 days
Secondary Risk factors of mortality and major complications after open aortic surgery To identify risk factors eg. smoking, type of surgery, age, etc. 30 days
Secondary Risk factors of mortality and major complications after TEVAR To identify risk factors eg. smoking, diagnosis, age, etc. 30 days
Secondary Risk factors of mortality and major complications after EVAR To identify risk factors eg. smoking, age, etc. 30 days
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk